ResMed | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Ansell USD 58.65M 19.15M 2024-06
AtriCure USD -14523000 7.12M 2024-12
Baxter International USD -435000000 590M 2024-12
Cochlear AUD 220.1M 34.8M 2024-06
Cooper Companies USD 182M 16.4M 2025-01
CSL USD 1.2B 1.41B 2024-06
Dexcom USD 188.9M 36.9M 2024-12
Edwards Lifesciences USD 312.6M 38M 2024-12
Fisher Paykel Healthcare NZD 218.1M 115.4M 2024-09
Globus Medical USD 60.27M 12.18M 2024-12
Haemonetics USD 59.03M 7.33M 2024-12
Hologic USD 229.8M 200K 2024-12
Idexx Laboratories USD 261.69M 42.21M 2024-12
Insulet USD 109.3M 21.2M 2024-12
Integra LifeSciences USD 35.23M 43.36M 2024-12
Intuitive Surgical USD 734.9M 157.6M 2024-12
Masimo USD -359100000 389.2M 2024-12
Medtronic USD 1.65B 51M 2025-01
Philips EUR 199M 139M 2024-12
Ramsay Health Care AUD 200M 285.4M 2024-12
ResMed USD 417.24M 29.93M 2024-12
Sigma Healthcare AUD 6.86M 6.05M 2024-07
Sonic Healthcare AUD 435.76M 193.66M 2024-12
Steris USD 245.4M 31.97M 2024-12
Teleflex USD -110383000 259.69M 2024-12
Thermo Fisher Scientific USD 2.02B 178M 2024-12



ResMed Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.